Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-14T18:49:45.321Z Has data issue: false hasContentIssue false

Section 9 - Malignant Conditions

Published online by Cambridge University Press:  01 February 2018

Edited by
Sue Pavord  and
Beverley Hunt
Sue Pavord
Affiliation:
University of Oxford
Beverley Hunt
Affiliation:
King's College London
Get access
Type
Chapter
Information
The Obstetric Hematology Manual , pp. 293 - 332
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References

Barbui, T, Finazzi, G. Myeloproliferative disease in pregnancy and other management issues. Hematology 2006; 1: 246–252.CrossRefGoogle Scholar
Robinson, S, Bewley, S, Hunt, BJ, Radia, DH, Harrison, CN. The management and outcome of 18 pregnancies in women with polycythemia vera. Hematologica 2005; 90: 1477–1483.Google Scholar
Tupule, S, Bewley, S, Robinson, SE et al. The management and outcome of 4 pregnancies in women with idiopathic myelofibrosis. British Journal of Haematology 2008; 142: 480–482.CrossRefGoogle Scholar
Nangalia, J, Massie, CE, Baxter, EJ et al. Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2. New England Journal of Medicine 2013; 369: 2391–2405.Google Scholar
Klampfl, T, Gisslinger, H, Harutyunyan, AS et al. Somatic mutations of calreticulin in myeloproliferative neoplasms. New England Journal of Medicine 2013; 369: 2379–2390.CrossRefGoogle ScholarPubMed
Passamonti, F, Randi, ML, Rumi, E et al. Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617 V>F) mutation. Blood 2007; 110(2); 485–489.Google Scholar
Passamonti, F, Rumi, E, Randi, ML. Aspirin in pregnant patients with essential thrombocythemia: a retrospective analysis of 129 patients. Journal of Thrombosis and Hemostasis 2010; 8: 411–413.Google Scholar
Melillo, L, Tieghi, A, Candoni, A et al. Outcome of 122 pregnancies in essential thrombocythemia patients: a report from the Italian registry. American Journal Hematology 2009; 84: 636–640.Google Scholar
Gangat, N, Wolanskyj, AP, Schwager, S et al. Predictors of pregnancy outcome in essential thrombocythemia: a single institution study of 63 pregnancies. European Journal of Haematology 2009; 82(5): 350–353.Google Scholar
Rumi, E, Bertozzi, I, Casetti, IC et al. Impact of mutational status on pregnancy outcome in patients with essential thrombocytemia. Hematologica 2015; 100(11): e443–e445.Google Scholar
Harrison, CN. Platelets and thrombosis in myeloproliferative diseases. Hematology 2005; 1: 409–415.CrossRefGoogle Scholar
McMullin, MF, Bareford, D, Campbell, P et al. Guidelines for the diagnosis, investigation and management of polycythemia/erythrocytosis. British Journal of Haematology 2005; 130: 174–195.Google Scholar
Bain, BJ. Blood Cells, 3rd edn. Oxford, UK: Blackwell Science; 1995.Google Scholar
Cnossen, JS, Morris, RK, Riet, GT et al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. Canadian Medical Association Journal 2008; 178(6): 701–711.Google Scholar
Llurba, E, Carreras, E, Gratacos, E et al. Maternal history and uterine artery doppler in the assessment of risk for development of early- and late-onset pre-eclampsia and intrauterine growth restriction. Obstetrics and Gynecology International 2009; Article ID 275613. doi:10.1155/2009/275613.Google Scholar
Bellucci, S, Janvier, M, Tobelem, G et al. Essential thrombocythemias: Clinical evolutionary and biological data. Cancer 1986; 58: 2440–2447.Google Scholar
Beard, J, Hillmen, P, Anderson, CC et al. Primary thrombocythemia in pregnancy. British Journal of Haematology 1991; 77: 371–374.Google Scholar
Leone, G, De Stefano, V, D’Addosio, A. Essential thrombocythemia pregnancy. Hematologica 1991; 76: 365–367.Google Scholar
Pagliaro, P, Arrigoni, L, Muggiasca, ML et al. Primary thrombocythemia and pregnancy: treatment and outcome in fifteen cases. American Journal of Hematology 1996; 53: 6–10.Google Scholar
Randi, ML, Rossi, C, Fabris, F, Girolami, A. Essential thrombocythemia in young adults: treatment and outcome of 16 pregnancies. Journal of Internal Medicine 1999; 246: 517–518.Google Scholar
Cincotta, R, Higgins, JR, Tippett, C et al. Managament of essential thrombocythemia during pregnancy. Australia and New Zealand Journal of Obstetrics and Gynecology 2000; 40: 33–37.CrossRefGoogle Scholar
Bangerter, M, Guthner, C, Beneke, H et al. Pregnancy in essential thrombocythemia: treatment and outcome of 17 pregnancies. European Journal of Haematology 2000; 65: 165–169.Google Scholar
Wright, CA, Tefferi, A. A single institutional experience with 43 pregnancies in essential thrombocythemia. European Journal of Haematology 2001; 66: 152–159.Google Scholar
Candoni, A, Fanin, R, Michelutti, T et al. Pregnancy and abortion in women with essential thrombocythemia. American Journal of Hematology 2002; 69: 233–234.Google Scholar
Niittyvuopio, R, Juvonen, E, Kaaja, R et al. Pregnancy in essential thrombocythemia: experience with 40 pregnancies. European Journal of Haematology 2004; 73: 434–436.CrossRefGoogle ScholarPubMed
Crowley, JP, Barcohana, Y, Sturner, WQ. Disseminated intravascular coagulation following first trimester abortion in polycythemia vera. Increased platelet count apparently contributed to fatal outcome. Rhode Island Medical Journal 1987; 70: 109–112.Google Scholar
Centrone, AL, Freda, RN, McGowan, L. Polycythemia rubra vera in pregnancy. Obstetrics and Gynecology 1967; 30: 657–659.Google Scholar
Ruch, WA, Klein, RL. Polycythemia vera and pregnancy: report of a case. Obstetrics and Gynecology 1964; 23: 107–111.Google ScholarPubMed
Subtil, D, Deruelle, P, Trillot, N, Jude, B. Preclinical phase of polycythemia vera in pregnancy. Obstetrics and Gynecology 2001; 98: 945–947.Google ScholarPubMed
Hochman, A, Stein, JA. Polycythemia and pregnancy. Report of a case. Obstetrics and Gynecology 1961; 18: 230–235.Google ScholarPubMed
Harris, RE, Conrad, FG. Polycythemia vera in the childbearing age. Archives of Internal Medicine 1967; 120: 697–700.CrossRefGoogle ScholarPubMed
Ruggeri, M, Tosetto, A, Castaman, G, Rodeghiero, F. Pulmonary embolism after pregnancy in a patient with polycythemia vera. American Journal of Hematology 2001; 67: 216–217.Google Scholar
Pata, O, Tok, CE, Yazici, G et al. Polycythemia vera and pregnancy: a case report with the use of hydroxyurea in the first trimester. American Journal of Perinatology 2004; 21: 135–137.Google Scholar
Robinson, S, Bewley, S, Hunt, BJ et al. The management and outcome of 18 pregnancies in women with polycythemia vera. Hematologica 2005; 90: 1477–1483.Google Scholar
Taylor, UB, Bardeguez, AD, Iglesias, N, Gascon, P. Idiopathic myelofibrosis in pregnancy: a case report and review of the literature. American Journal of Obstetrics and Gynecology 2004; 167: 38–39.Google Scholar
Gotic, M, Cvetkovic, M, Bozanovic, T, Cemerikic, V. [Successful treatment of primary myelofibrosis with thrombocytosis during pregnancy with alfa-interferon.] Srp Arh Celok Lek 2001; 129: 304–308.Google Scholar
Okoli, S, Wilkin, B, Robinson, S, Harrison, C. Diagnosis of a myeloproliferative disorder in late pregnancy. Obstetric Medicine 2013; 6(1): 26–27.Google Scholar

References

Swerdlow, SH, Campo, E, Pileri, SA. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016; 127: 2375–2390.Google Scholar
Cancer Research UK. Cancer Research UK Hodgkin Lymphoma Incidence Statistics; 2011. http://www.cancerresearchuk.org/cancer-info/cancerstats/types/hodgkinslymphoma/incidence/uk-hodgkins-lymphoma-incidence-statistics (accessed May 28 2015).Google Scholar
Pereg, D, Koren, G, Lishner, M. The treatment of Hodgkin’s and non-Hodgkin’s lymphoma in pregnancy. Hematologica 2007; 92: 1230–1237.CrossRefGoogle ScholarPubMed
Bachanova, V, Connors, JM. Hodgkin lymphoma in pregnancy. Current Hematologic Malignancy Reports 2013; 8: 211–217.Google Scholar
Rizack, T, Mega, A, Legare, R, Castillo, J. Management of hematological malignancies during pregnancy. American Journal of Hematology 2009; 84: 830–841.Google Scholar
Evens, A, Advani, R, Press, OW et al. Lymphoma occurring during pregnancy: antenatal therapy, complications, and maternal survival in a multicenter analysis. Journal of Clinical Oncology 2013; 32: 4132–4139.Google Scholar
Follows, GA, Ardeshna, KM, Barrington, SF et al.; on behalf of the British Committee for Standards in Hematology. Guidelines for the first line management of classical Hodgkin lymphoma. British Journal of Haematology 2014; 166: 34–49.Google Scholar
Horowitz, NA, Benyamini, N, Wohlfart, K, Brenner, B, Avivi, I. Reproductive organ involvement in non-Hodgkin lymphoma during pregnancy: a systematic review. Lancet Oncology 2013; 14: 275–282.Google Scholar
Eyre, TA, Lau, IJ, Mackillop, L, Collins, GP. Management and controversies of classical Hodgkin lymphoma in pregnancy. British Journal of Haematology 2015; 169: 613–630Google Scholar
Avilés, A, Natividad, N, Marıa-Jesus, N. Hematological malignancies and pregnancy: Treat or no treat during first trimester? International Journal of Cancer 2012; 131: 2678–2683.CrossRefGoogle ScholarPubMed
Avivi, I, Connors, JM, Brenner, B, Horowitz, NA. Non-Hodgkin lymphomas in pregnancy: Tackling therapeutic quandaries. Blood Reviews 2014; 28: 213–220.Google Scholar
Guven, S, Ozcebe, OI, Tuncer, ZS. Non-Hodgkin’s lymphoma complicating pregnancy: A case report. European Journal of Gynaecological Oncology 2005; 26: 457–458.Google Scholar
Decker, M, Rothermundt, C, Hollander, G, et al. Rituximab plus CHOP for treatment of diffuse large B-cell lymphoma during second trimester of pregnancy. Lancet Oncology 2006; 7: 693–694.CrossRefGoogle ScholarPubMed
Rey, J, Coso, D, Roger, V et al. Rituximab combined with chemotherapy for lymphoma during pregnancy. Leukemia Research 2009; 33: 8–9.Google Scholar
Chakravarty, EF, Murray, ER, Kelman, A, Farmer, P. Pregnancy outcomes after maternal exposure to rituximab. Blood 2011; 117 (5): 1499–1506.CrossRefGoogle ScholarPubMed
Antid, N, Colovid, M, Cemerikid, V et al. Disseminated Burkitt like lymphoma during pregnancy. Medical Oncology 2000; 17; 233–236.Google Scholar
Magloire, LK, Pattker, CM, Buhimschi, CS, Funai, EF. Burkitt’s lymphoma of the ovary in pregnancy. American Journal of Obstetrics and Gynecology 2006; 108(3): 743–745.Google Scholar
Petersen, C, Lester, DR, Sanger, W. Burkitts lymphoma in early pregnancy. Journal of Clinical Oncology 2010; 28 (9): 136–138.CrossRefGoogle Scholar
Amant, F, Van Calsteren, K, Halaska, MJ. Long-term cognitive and cardiac outcomes after prenatal exposure to chemotherapy in children aged 18 months or older: An observational study. Lancet Oncology 2012; 13: 256–264.Google Scholar
Amant, F, Han, SN, Gziri, MM, Dekrem, J, Van Calsteren, K. Chemotherapy during pregnancy. Current Opinion in Oncology 2012; 24(5): 580–586.CrossRefGoogle ScholarPubMed
Hurley, TJ, McKinnel, JV, Irani, MS. Hematologic malignancies in pregnancy. Obstetric and Gynecology Clinics of North America 2005; 32: 595–614.Google Scholar
Gziri, MM. Effects of chemotherapy during pregnancy on the maternal and fetal heart. Prenatal Diagnosis 2012; 32(7): 614–619.Google Scholar
Greenlund, LJ, Letendre, L, Tefferi, A. Acute leukemia during pregnancy: a single institutional experience with 17 cases. Leukemia and Lymphoma 2001; 41: 571–577.CrossRefGoogle ScholarPubMed
Cardonick, E, Iacobucci, A. Use of chemotherapy during human pregnancy. Lancet Oncology 2004; 5: 283–291.Google Scholar
Reynoso, EE, Shepherd, FA, Messner, HA et al. Acute leukemia during pregnancy: the Toronto Leukemia Study Group experience with long-term follow-up of children exposed in utero to chemotherapeutic agents. Journal of Clinical Oncology 1987; 5: 1098–1106.CrossRefGoogle Scholar
Cheghoum, Y, Vey, N, Raffoux, E et al. Acute leukemia during pregnancy: a report on 37 patients and a review of the literature. Cancer 2005; 104: 110–117.CrossRefGoogle Scholar
Meyer-Wittkopf, M, Barth, H, Emons, G, Schmidt, S. Fetal cardiac effects of doxorubicin therapy for carcinoma of the breast during pregnancy: case report and review of the literature. Ultrasound in Obstetrics and Gynecology 2001; 18: 62–66.Google Scholar
Shapira, T, Pereg, D, Lishner, M. How I treat acute and chronic leukemia in pregnancy. Blood Reviews 2008; 22: 247–259.CrossRefGoogle Scholar
Wagner, VM, Hill, JS, Weaver, D, Behner, RL. Congenital abnormalities in baby born to cytarabine treated mother. Lancet 1980; 316: 98–99.CrossRefGoogle Scholar
Artlich, A, Möller, J, Kruse, K et al. Teratogenic effects in a case of maternal treatment for acute myelocytic leukemia – neonatal and infantile course. European Journal of Pediatrics 1994; 153: 488–491.Google Scholar
Schafer, AI. Teratogenic effects of antileukemic chemotherapy. Archives of Internal Medicine 1981; 141: 514–515.Google Scholar
Avilés, A, Niz, J. Long-term follow-up of children born to mothers with acute leukemia during pregnancy. Medical and Pediatric Oncology 1988; 16: 3–6.Google Scholar
Cantini, E, Yanes, B. Acute myelogenous leukemia in pregnancy. Southern Medical Journal 1984; 77: 1050–1052.Google Scholar
Breccia, M, Mengarelli, A, Mancini, M et al. Myelodysplastic syndromes in patients under 50 years old: a single institution experience. Leukemia Research 2005; 29: 749–754.Google Scholar
Ikeda, Y, Masuzaki, H, Nakayama, D et al. Successful management and perinatal outcome of pregnancy complicated with myelodysplastic syndrome. Leukemia Research 2002; 26: 255–260.Google Scholar
Siddiqui, T, Elfenbein, GJ, Noyes, WD et al. Myelodysplastic syndromes presenting in pregnancy. A report of five cases and the clinical outcome. Cancer 1990; 66: 377–381.Google Scholar
Pagliuca, A, Mufti, GJ, Fenaux, P et al. Myelodysplastic syndromes during pregnancy. European Journal of Hematology 1991; 47: 310–312.Google Scholar
Fadilah, SA, Roswati, MN. Refractory anemia with excess of blasts in transformation (RAEB-T) during pregnancy with hematological remission following delivery. British Journal of Haematology 1999; 104: 935–936.Google Scholar
Essien, EM, Sharma, U, Upadhaya, K, Malik, R. Myelodysplastic syndrome and successful pregnancy. International Journal of Hematology 1998; 68: 449–452.Google Scholar
Yang, Z, Mei-Ying, L, Shan-Mi, W, Xiao-Hui, Z. Pregnancy and myelodysplastic syndrome: an analysis of the clinical characteristics, maternal and fetal outcomes. Journal of Maternal and Fetal Neonatal Medicine 2015; 28(18): 2155–2159.Google Scholar
Hellstrom-Lindberg, E. Efficacy of erythropoietin in the myelodysplastic syndromes: a meta-analysis of 205 patients from 17 studies. British Journal of Haematology 1995; 89: 67–71.CrossRefGoogle ScholarPubMed
Royal College of Obstetricians and Gynecologists. Bacterial Sepsis following Pregnancy. Green-Top Clinical Guideline No. 64b. London: Royal College of Obstetricians and Gynecologists; 2012. http://www.rcog.org.uk/files/rcog-corp/11.6.12GTG64b.pdf (accessed June 1 2014).Google Scholar
Einarson, A, Maltepe, C, Navioz, Y et al. The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study. British Journal of Obstetrics and Gynecology 2004; 111: 940–943.CrossRefGoogle ScholarPubMed
Lynch, CM, Herold, AH. Use of antibiotics during pregnancy. Medical News and Events, 1991. http://www.drplace.com/Use_of_antibiotics_during_pregnancy.16.18138.htm (accessed July 11 2017).Google Scholar
King, CT, Rogers, PD, Cleary, JD Chapman, SW. Antifungal therapy during pregnancy. Clinical Infectious Diseases 1998; 27: 1151–1160.CrossRefGoogle ScholarPubMed
The Advisory Committee on the Safety of Blood, Tissues and Organs (SaBTO) position statement. Provision of cytomegalovirus tested blood components position statement; 2012. https://www.gov.uk/government/news/provision-of-cytomegalovirus-tested-blood-components-position-statement-published (accessed July 11 2017).Google Scholar
Royal College of Obstetricians and Gynecologists. Green-Top Clinical Guideline No. 7 Antenatal Corticosteroids to Reduce Neonatal Morbidity and Mortality. London: Royal College of Obstetricians and Gynecologists; 2010. http://www.rcog.org.uk/files/rcog-corp/GTG%207.pdf (accessed June 1 2014).Google Scholar
RCOG. Magnesium Sulphate to Prevent Cerebral Palsy following Preterm Birth. RCOG Scientific Impact Paper No.29. 2011. https://www.rcog.org.uk/globalassets/documents/guidelines/scientific-impact-papers/sip_29.pdf (accessed June 1 2014).Google Scholar
Qureshi, H, Masse, E, Kirwan, D et al. BCSH guideline for the use of anti-D immunoglobulin for the prevention of hemolytic disease of the fetus and newborn. Transfusion Medicine 2014; 24: 8–20.Google Scholar

References

Meirow, D, Dor, J, Kaufman, A et al. Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury. Human Reproduction 2007; 22: 1626–1633.Google Scholar
Tilly, JL. Pharmacological protection of female infertility. In Tulandi, T, Gosden, R (eds) Preservation of Fertility. London:Taylor and Francis; 2004: 65–75.Google Scholar
Kalich-Philosoph, L, Roness, H, Carmely, A et al. Cyclophosphamide triggers follicle activation and ‘burnout’; AS101 prevents follicle loss and preserves fertility. Science Translational Medicine 2013; 5: 185ra62Google Scholar
Peigne, M, Decanter, C. Serum AMH level as a marker of acute and long-term effects of chemotherapy on the ovarian follicular content: a systematic review. Reproductive Biology and Endocrinology 2014; 12: 26.Google Scholar
Critchley, HO, Wallace, WH, Shalet, SM et al. Abdominal irradiation in childhood: the potential for pregnancy. British Journal of Obstetrics and Gynecology 1992; 97: 804–810.Google Scholar
Wallace, WHB, Thomson, AB, Kelsey, TW. The radiosensitivity of the human oocyte. Human Reproduction 2003; 18: 117–121.Google Scholar
Littley, MD, Shalet, SM, Beardwell, CG et al. Hypopituitarism following external radiotherapy for pituitary tumours in adults. Quaterley Journal of Medicine 1989; 70: 145–160.Google ScholarPubMed
Green, DM, Nolan, VG, Kawashima, MS et al. Decreased fertility among female childhood cancer survivors who received 22-27 G hypothalamic/pituitary irradiation: a report from the childhood cancer survivor study. Fertility and Sterility 2011; 95: 1922–1927.Google Scholar
Sudour, H, Chastagner, P, Claude, L, et al. Fertility and pregnancy outcome after abdominal irradiation that included or excluded the pelvis in childhood tumor survivors. International Journal of Radiation Oncology Biology Physics 2010; 76: 867–873.Google Scholar
The, T, Stern, C, Chander, S, Hickey, M. The impact of uterine radiation on subsequent fertility and pregnancy outcomes. BioMed Research International 2014; Article ID 482968.Google Scholar
Sanders, JE, Buckner, CD, Amos, D et al. Ovarian function following marrow transplantation for aplastic anemia or leukemia. Journal of Clinical Oncology 1988; 6: 813–818.Google Scholar
Holm, K, Nysom, K, Brocks, V et al. Ultrasound B-mode changes in the uterus and ovaries and Doppler changes in the uterus after total body irradiation and allogeneic bone marrow transplantation. Bone Marrow Transplantation 1999; 23: 259–263.Google Scholar
Meirow, D. Reproduction post-chemotherapy in young cancer patients. Molecular Cell Endocrinology 2000; 169: 123–131.Google Scholar
Koyama, H, Wada, T, Nishizawa, Y et al. Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer. Cancer 1977; 39: 1403–1409.Google Scholar
Sanders, JE, Hawley, J, Levy, W et al. Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 1996; 87: 3045–3052.Google Scholar
Salooja, N, Szydlo, RM, Socie, G et al. Pregnancy outcomes after peripheral blood or bone marrow transplantation: a retrospective study. Lancet 2001; 358: 271–276.Google Scholar
Callis, L, Nieto, J, Vila, A, Rende, J. Chlorambucil treatment in minimal lesion nephrotic syndrome: a reappraisal of its gonadal toxicity. Journal of Pediatrics 1980; 97: 653–656.Google Scholar
Freckman, HA, Fry, HL, Mendez, FL et al. Chlorambucil–prednisolone therapy for disseminated breast carcinoma. Journal of the American Medical Society 1964; 189: 23–26.Google Scholar
Chemaitilly, W, Mertens, AC, Mitby, P et al. Acute ovarian failure in the Childhood Cancer Survivor Study. Journal of Clinical Endocrinology and Metabolism 2006; 91: 1723–1728.Google Scholar
Pye, S, Cortes, J, Ault, P et al. The effects of imatinib on pregnancy outcome. Blood 2008; 111: 5505–5508.Google Scholar
Christopoulos, C, Dimakopoulou, V, Rotas, E. Primary ovarian insufficiency associated with imatinib therapy. New England Journal of Medicine 2008; 358: 1079–1080.CrossRefGoogle ScholarPubMed
Meirow, D, Dor, J. Epidemiology and infertility in cancer patients. In Tulandi, T, Gosden, R (eds) Preservation of Fertility. London:Taylor and Francis; 2004: 21–38.Google Scholar
Chakravarty, E, Murray, E, Kelman, A et al. Pregnancy outcomes after maternal exposure to rituximab. Blood 2011; 117: 1499–1506.Google Scholar
Dann, EJ, Epelbaum, R, Avivi, I et al. Fertility and ovarian function are preserved in women treated with an intensified regimen of cyclophosphamide, adriamycin, vincristine and prednisone (Mega-CHOP) for non-Hodgkin lymphoma. Human Reproduction 2005; 20; 2247–2249.Google Scholar
Meirow, D. Reproduction post-chemotherapy in young cancer patients. Molecular Cell Endocrinology 2000; 169: 123–131.Google Scholar
Steffens, M, Beauloye, V, Brichard, B et al. Endocrine and metabolic disorders in young adult survivors of childhood acute lymphoblastic leukemia (ALL) or non-Hodgkin lymphoma (NHL). Clinical Endocrinology 2008; 69: 819–827.Google Scholar
Huakvik, UKH, Dieset, I, Bjoro, T, Holte, H, Fossa, SD. Treatment-related premature ovarian failure as a long-term complication after Hodgkin’s lymphoma. Annals of Oncology 2006; 17: 1428–1433.Google Scholar
Cabañas-Perianes, V, Macizo, M, Salido, E et al. Management of multiple myeloma during pregnancy: a case report and review. Hematological Oncology 2016; 34(2): 108–114.Google Scholar
Green, DM, Whitton, JA, Stovall, M et al. Pregnancy outcomes in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. American Journal of Obstetrics and Gynecology 2002; 187: 1070–1080.Google Scholar
Winther, JW, Olsen, JH, Wu, H et al. Genetic disease in the children of Danish surviors of childhood and adolescent cancer. Journal of Clinical Oncology 2012; 30: 27–33.Google Scholar
Signorello, LB, Mulvihill, JJ, Green, DM et al. Congenital anomalies in the children of cancer survivors: a report from the childhood cancer survivor study. Journal of Clinical Oncology 2012; 30: 239–245.Google Scholar
Bachanova, V, Connors, JM. Hodkgin lymphoma in pregnancy. Current Hematologic Malignancy Reports 2013; 8: 211–217.Google Scholar
Ali, S, Jones, GL, Culligan, DJ et al. Guidelines for the management of acute myelod leukemia in pregnancy. British Journal of Haematology 2015; 170: 487–495.Google Scholar
Eyre, TA, Lau, IJ, Mackillop, L, Collins, GP. Classical Hodgkins lymphoma and pregnancy. British Journal of Haematology 2015; 69: 613–630.Google Scholar
Royal College of Physicians, Royal College of Radiologists and RCOG. The Effects of Cancer Treatment on Reproductive Function. Guidance on Management. London: RCP; 2007.Google Scholar
NICE. NICE Clinical Guideline 156. Fertility: Assessment and Treatment for People with Fertility Problems; 2013. https://www.nice.org.ukGoogle Scholar
The Ethics Committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion. Fertility and Sterility 2013; 100: 1224–1231.Google Scholar
Loren, AW, Mangu, PB, Beck, LN et al. Fertility preservation for patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. Journal of Clinical Oncology 2013; 31: 2500–2510.Google Scholar
Cakmak, H, Katz, A, Cedars, MI, Rosen, MP. Effective method for emergency fertility preservation: random-start controlled ovarian stimulation. Fertility and Sterility 2013; 100: 1673–1680.Google Scholar
Kuang, Y, Hong, Q, Chen, Q et al. Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles. Fertility and Sterility 2014; 101: 105–111.CrossRefGoogle ScholarPubMed
Donnez, J, Dolmans, M, Pellicer, A et al. Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation. Fertility and Sterility 2013; 99: 1503–1513.Google Scholar
Dolmans, M, Marinescu, C, Saussoy, P et al. Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe. Blood 2010; 116: 2908–2914.Google Scholar
Rosendahl, M, Greve, T, Anderson, CY. The safety of transplanting cryopreserved ovarian tissue in cancer patients: a review of the literature. Journal of Assisted Reproduction and Genetics 2012; 30: 11–24.Google Scholar
Lockwood, GM. Whose embryos are they anyway? Clinical Ethics 2007; 2: 56–58.Google Scholar
Meirow, D, Dor, J. Epidemiology and infertility in cancer patients. In Tulandi, T, Gosden, R (eds) Preservation of Fertility. London:Taylor and Francis; 2004: 31.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×